Cite
Targeting Neural-Restrictive Silencer Factor Sensitizes Tumor Cells to Antibody-Based Cancer Immunotherapy In Vitro via Multiple Mechanisms
MLA
Rossen M. Donev, et al. “Targeting Neural-Restrictive Silencer Factor Sensitizes Tumor Cells to Antibody-Based Cancer Immunotherapy In Vitro via Multiple Mechanisms.” The Journal of Immunology, vol. 184, June 2010, pp. 6035–42. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cb7d7989df8b4d50785075fb5848ffbf&authtype=sso&custid=ns315887.
APA
Rossen M. Donev, B. Paul Morgan, Marieta M. Ruseva, & Martin Kolev. (2010). Targeting Neural-Restrictive Silencer Factor Sensitizes Tumor Cells to Antibody-Based Cancer Immunotherapy In Vitro via Multiple Mechanisms. The Journal of Immunology, 184, 6035–6042.
Chicago
Rossen M. Donev, B. Paul Morgan, Marieta M. Ruseva, and Martin Kolev. 2010. “Targeting Neural-Restrictive Silencer Factor Sensitizes Tumor Cells to Antibody-Based Cancer Immunotherapy In Vitro via Multiple Mechanisms.” The Journal of Immunology 184 (June): 6035–42. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cb7d7989df8b4d50785075fb5848ffbf&authtype=sso&custid=ns315887.